Search by Drug Name or NDC

    NDC 68180-0407-04 CEFIXIME 200 mg/5mL Details

    CEFIXIME 200 mg/5mL

    CEFIXIME is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is CEFIXIME.

    Product Information

    NDC 68180-0407
    Product ID 68180-407_8b1eb90e-2cfa-4ea7-b191-66017220852b
    Associated GPIs 02300060001920
    GCN Sequence Number 044428
    GCN Sequence Number Description cefixime SUSP RECON 200 MG/5ML ORAL
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 92368
    HICL Sequence Number 003999
    HICL Sequence Number Description CEFIXIME
    Brand/Generic Generic
    Proprietary Name CEFIXIME
    Proprietary Name Suffix n/a
    Non-Proprietary Name CEFIXIME
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/5mL
    Substance Name CEFIXIME
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065355
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0407-04 (68180040704)

    NDC Package Code 68180-407-04
    Billing NDC 68180040704
    Package 75 mL in 1 BOTTLE (68180-407-04)
    Marketing Start Date 2015-04-24
    NDC Exclude Flag N
    Pricing Information N/A